Deborah Birx
Director Ejecutivo en ARMATA PHARMACEUTICALS, INC. .
Fortuna: 2 M $ al 31/05/2024
Cargos activos de Deborah Birx
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ARMATA PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 11/07/2023 | - |
| Director Ejecutivo | 11/07/2023 | - | |
Nanolive SA
 Nanolive SA Medical SpecialtiesHealth Technology Nanolive SA develops revolutionary tomographic microscope to look instantly inside living cells in 3D. Its device scans cell division, cell organelles and cell morphology, cell differentiation, cell-cell interaction, intracellular trafficking, cellular remodeling processes, drug monitoring, and in vitro fertilization. The company was founded in November 2013 by Yann Cotte, Sebastien Equis, and Andreas Kern, Fatih Toy, Christian Depeursinge and is headquartered in Ecublens, Switzerland. | Director/Miembro de la Junta | - | - |
Historial de carrera de Deborah Birx
Antiguos cargos conocidos de Deborah Birx.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| INNOVIVA, INC. | Director/Miembro de la Junta | 09/03/2021 | 10/07/2023 |
| Independent Dir/Board Member | 09/03/2021 | 10/07/2023 |
Formación de Deborah Birx.
| Houghton College | Undergraduate Degree |
| Pennsylvania State University College of Medicine | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
| Suiza | 2 |
Operativa
| Director/Board Member | 3 |
| Independent Dir/Board Member | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| INNOVIVA, INC. | Health Technology |
| ARMATA PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Nanolive SA
Nanolive SA Medical SpecialtiesHealth Technology Nanolive SA develops revolutionary tomographic microscope to look instantly inside living cells in 3D. Its device scans cell division, cell organelles and cell morphology, cell differentiation, cell-cell interaction, intracellular trafficking, cellular remodeling processes, drug monitoring, and in vitro fertilization. The company was founded in November 2013 by Yann Cotte, Sebastien Equis, and Andreas Kern, Fatih Toy, Christian Depeursinge and is headquartered in Ecublens, Switzerland. | Health Technology |
- Bolsa de valores
- Insiders
- Deborah Birx
- Experiencia
